Insiders · Profile

Wolff Allen

CFO and EVP at Ernexa Therapeutics. Filing since 21 May 2015. CIK 0001628529

Company
Date
Role
Action
Shares
Amount
Of holding
13 Jun 2016
CFO and EVP
Bought
15,000
$1.79K
18.6%
16 Mar 2016
CFO and EVP
Bought
10,000
$1.86K
14.2%
16 Mar 2016
CFO and EVP
Bought
5,000
$914.00
7.6%
21 May 2015
CFO
Bought
65,500
$23.58K
opened
4 decisions on file.